Great West Life Assurance CO Omeros Corp Transaction History

Great West Life Assurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.92 - $6.28 $5,687 - $18,601	-2,962 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$9.57 - $21.32 $54,434 - $121,268	-5,688 Reduced 65.76%	2,962 $29,000
Q3 2020 Nov 13, 2020	BUY	$9.57 - $21.32 $54,434 - $121,268	5,688 Added 192.03%	8,650 $87,000
Q4 2019 Feb 11, 2020	BUY	$13.01 - $17.15 $38,535 - $50,798	2,962 New	2,962 $41,000
Q3 2019 Oct 25, 2019	SELL	$14.55 - $20.56 $81,218 - $114,765	-5,582 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$15.0 - $19.62 $31,515 - $41,221	-2,101 Reduced 27.35%	5,582 $0
Q1 2019 May 08, 2019	BUY	$11.65 - $17.72 $50,514 - $76,833	4,336 Added 129.55%	7,683 $133,000
Q3 2017 Nov 09, 2017	BUY	$19.76 - $24.9 $66,136 - $83,340	3,347	3,347 $70,000

112

25.5M

317K

556K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $246M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.